Endosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis

Sponsor
Western Galilee Hospital-Nahariya (Other)
Overall Status
Unknown status
CT.gov ID
NCT03083392
Collaborator
(none)
20
1
1
24
0.8

Study Details

Study Description

Brief Summary

This study is intended to evaluate the efficiency of utilizing "dynamic implant valve approach" (DIVA) system in treating chronic maxillary sinusitis.

Condition or Disease Intervention/Treatment Phase
  • Procedure: treatment of chronic maxillary sinusitis using DIVA system
  • Device: "dynamic implant valve approach" - DIVA system
N/A

Detailed Description

A prospective study aimed to test the efficiency of a minimal interventional approach in treating chronic maxillary sinusitis. The "dynamic implant valve approach" (DIVA), a minimally invasive approach utilizes a dental implant, designed with an internal sealing screw that might serve as drug delivery system via its channel. The implant is inserted to a posterior maxillary edentulous area, creating a connection between the sinus cavity and the oral cavity (Oro-antral connection), hence, provides a controlled working channel for diagnosis and treatment of the disease (e.g; allowing drainage, lavage and sinus endoscopy). The implant is a medical device approved for use at the anatomical area of interest.

The treatment method proposed in this study is based on the principle of a conventional treatment of washing the maxillary sinus cavity called "Antral puncture and lavage".

The changes that are proposed in this study could make the operation more convenient and effective in the therapeutic level, both for the patient and the clinician for the following reasons:

  • DIVA (Dynamic Implant Valve Approach) Implant with a multi- useful working channel: the mere presence of the canal in the center of the implant with a screw seal, ensures controlled Oro-antral connection, and enables multiple endoscopy and lavage procedures until resolution of the pathological condition is achieved.

  • The anatomical location of the puncture / penetration to the sinus - is performed in the maxillary edentulous region. This is the lowest area of the sinus cavity (standing or sitting posture), which utilizes gravity for drainage and extraction of the contaminated contents of the sinus.

By appropriate advance planning, the implant, after eradication of the disease, can later be used for prosthetic purposes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Endosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis
Anticipated Study Start Date :
Mar 1, 2017
Anticipated Primary Completion Date :
Mar 1, 2018
Anticipated Study Completion Date :
Mar 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment

treatment of chronic maxillary sinusitis using DIVA system

Procedure: treatment of chronic maxillary sinusitis using DIVA system
chronic maxillary sinusitis treatment utilizing DIVA system for antral lavage

Device: "dynamic implant valve approach" - DIVA system
The DIVA system will be used to apply saline lavage to the maxillary sinus

Outcome Measures

Primary Outcome Measures

  1. resolution of chronic maxillary sinusitis [three months]

    After three months of follow-up, the patient will be assessed by a combination of medical tests (clinical, endoscopic and radiologic assessment), in order to determine if the maxillary sinusitis has completely resolved. The investigators expect to see complete resolution of the sinus pathological state (e.g. no evidence of sinusitis)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • No medical history of diseases involving bone metabolism

  • Unilateral or bilateral maxillary sinusitis, as evident by radiographic and endoscopic modaleties, which have not responded to optimal conservative treatment

  • Patient who is edentulous in the maxillary region and is interested in dental implant

  • The patient does not participate in another clinical study

  • The patient can read and understand the informed consent

Exclusion Criteria:
  • Medical history of increased risk of developing bone necrosis (MRONJ - medically related osteonecrosis of the jaw , or ORN - osteoradionecrosis)

  • patients who are not interested or need dental implants

  • Patients with maxillary sinus neoplastic pathology

  • Chronic maxillary sinusitis with polyps

  • Pregnant women

Contacts and Locations

Locations

Site City State Country Postal Code
1 Western Galilee Medical Center Nahariya Israel

Sponsors and Collaborators

  • Western Galilee Hospital-Nahariya

Investigators

  • Study Director: Samer Srouji, Prof., Western Galilee Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
ruth angel dar, Principal Investigator, Western Galilee Hospital-Nahariya
ClinicalTrials.gov Identifier:
NCT03083392
Other Study ID Numbers:
  • 0015-17-NHR
First Posted:
Mar 20, 2017
Last Update Posted:
Mar 20, 2017
Last Verified:
Mar 1, 2017
Keywords provided by ruth angel dar, Principal Investigator, Western Galilee Hospital-Nahariya
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 20, 2017